You are here

  • Home
  • Archive
  • Volume 12, Issue 7
  • Can screening for degenerative cervical myelopathy (SCREEN-DCM) be effectively undertaken based on signs, symptoms and known risk factors? Rationale and research protocol for a prospective, multicentre, observational study

Citation Tools

Article menu

Download PDFPDF

Neurology
Protocol
Can screening for degenerative cervical myelopathy (SCREEN-DCM) be effectively undertaken based on signs, symptoms and known risk factors? Rationale and research protocol for a prospective, multicentre, observational study

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Nouri A, Molliqaj G, Gondar R, et al
Can screening for degenerative cervical myelopathy (SCREEN-DCM) be effectively undertaken based on signs, symptoms and known risk factors? Rationale and research protocol for a prospective, multicentre, observational study
BMJ Open 2022;12:e060689. doi: 10.1136/bmjopen-2021-060689